期刊文献+

Synergistic curative effect of chicory extract and cisplatin against thioacetamide-induced hepatocellular carcinoma 被引量:1

原文传递
导出
摘要 Aim:Hepatocellular carcinoma(HCC)is the dominant form of primary liver cancer and is histologically and etiologically distinct from other forms of primary liver cancer.The objective of this study was to elucidate the synergistic effect and the role of chicory extract[inulin(IN)]as a chemo-sensitizer for cisplatin(CIS)treatment of HCC.Methods:Five groups of rats were treated for 4 months.These groups consisted of the control group,a group receiving thioacetamide(TAA)(200 mg/kg b.w)in drinking water,a group injected intraperitoneally with a single dose of CIS(7.5 mg/kg b.w)in addition to TAA for 4 months,a group receiving oral doses of IN(10 mg/kg b.w)in addition to TAA for 4 months,and a group injected intraperitoneally with a single dose of CIS(7.5 mg/kg b.w)and IN(10 mg/kg b.w)plus TAA for 4 months.Results:The current data exhibited increment of serum and liver enzyme(alanine aminotransferase,aspartate aminotransferase,alkaline phosphatase,creatine kinase,and lactate dehydrogenase)activity,serum lipid profi le levels(total lipids,total cholesterol,triglycerides,low-density lipoprotein,and very low-density lipoprotein),and a signifi cant increase inα-fetoprotein and bilirubin,accompanied with reduced total serum protein and albumin levels in a HCC rat model.Histopathologically,numerous alterations were detected in hepatic tissues of HCC rats,such as lymphocytic cell infi ltration,damage of hepatocytes,dilated congested central vein with degenerated endothelial cells,and congested blood sinusoids in addition to Masson’s trichrome staining blue collagen fi bers in hepatocytes and central vein indicating hepatic fi brosis.Treatment of HCC rats with CIS or IN improved such deleterious effects,where IN is more effective than CIS,and the best effect can be observed in rats that received both CIS and IN.Conclusion:It could be concluded that IN in chicory extract acts as a chemo-sensitizer to CIS for treatment in an HCC rat model.
出处 《Hepatoma Research》 2015年第1期147-154,共8页 肝癌研究(英文版)
  • 相关文献

参考文献1

二级参考文献194

  • 1王广良,陈成彬,高建明,倪虹,王同顺,陈力.细胞周期相关基因微阵列在中药抑制肝癌细胞增殖作用机理研究中的应用[J].中国中药杂志,2005,30(1):50-54. 被引量:13
  • 2Ze Tian,Geng Lin,Rui-Xia Zheng,Feng Huang,Meng-Su Yang,Pei-Gen Xiao.Anti-hepatoma activity and mechanism of ursolic acid and its derivatives isolated from Aralia decaisneana[J].World Journal of Gastroenterology,2006,12(6):874-879. 被引量:31
  • 3Llovet JM,Burroughs A,Bruix J.Hepatocellular carcinomaThe Lancet,2003.
  • 4Ovesna Z,Vachalkova A,Horvathova K,et al.Pentacyclic triterpenoic acids: new chemoprotective compoundsNeoplasma,2004.
  • 5Jemal A,Siegel R,Xu J,et al.Cancer Statistics,2010CA A Cancer Journal for Clinicians,2010.
  • 6Llovet JM,Ricci S,Mazzaferro V,Hilgard P,Gane E,Blanc JF,de Oliveira AC,Santoro A,Raoul JL,Forner A,Schwartz M,Porta C,Zeuzem S,Bolondi L,Greten TF,Galle PR,Seitz JF,Borbath I,Haussinger D,Giannaris T,Shan M,Moscovici M,Voliotis D,Bruix J.Sorafenib in advanced hepatocellular carcinoma. The New England Journal of Medicine . 2008
  • 7Bruix J,Sherman M,Llovet JM,et al.Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. Journal of Hepatology . 2001
  • 8Bosch FX,Ribes J,Diaz M,et al.Primary liver cancer: worldwide incidence and trends. Gastroenterology . 2004
  • 9Josep M. Llovet.Updated treatment approach to hepatocellular carcinoma[J]. Journal of Gastroenterology . 2005 (3)
  • 10Wayne JD,Lauwers GY,Ikai I,Doherty DA,Belghiti J,Yamaoka Y,Regimbeau JM,Nagorney DM,Do KA,Ellis LM,Curley SA,Pollock RE,Vauthey JN.Preoperative predictors of survival after resection of small hepatocellular carcinomas. Annals of Surgery . 2002

共引文献6

同被引文献1

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部